v3.26.1
Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Numerator        
Net income $ 36,205 $ 9,272 $ 40,151 $ 5,950
Less: Net income attributable to noncontrolling interest (2,764) (1,813) (3,597) (1,128)
Net income attributable to Bioventus Inc. $ 33,441 $ 7,459 $ 36,554 $ 4,822
Denominator        
Basic weighted-average shares of Class A common stock outstanding (in shares) 67,869,148 66,500,433 67,589,178 66,258,679
Dilutive effect of stock options (in shares) 1,276,983 826,918 1,188,120 1,090,214
Dilutive effect of restricted stock units (in shares) 1,692,355 1,209,408 1,652,527 1,416,698
Diluted weighted-average shares of Class A common stock outstanding (in shares) 70,838,486 68,536,759 70,429,825 68,765,591
Net income per share of Class A common stock—basic (in dollars per share) $ 0.49 $ 0.11 $ 0.54 $ 0.07
Net income per share of Class A common stock—diluted (in dollars per share) $ 0.47 $ 0.11 $ 0.52 $ 0.07